Cargando…
PNS21 From Disease Burden to Healthcare Cost: Highlighting the Health Economics Aspects of the COVID-19 Pandemic
Autores principales: | Athanasakis, K., Nomikos, N., Souliotis, K., Kyriopoulos, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728561/ http://dx.doi.org/10.1016/j.jval.2020.08.1465 |
Ejemplares similares
-
HPR118 An Updated Estimate of the Direct Cost of the COVID-19 Pandemic for the Greek Healthcare System
por: Athanasakis, K, et al.
Publicado: (2022) -
Cost–Benefit Analysis of Single versus Repeated Use of Single-Use Devices in Cataract Surgery
por: Naoum, Panagiota, et al.
Publicado: (2021) -
Investigating the Value of Abatacept in the Treatment of Rheumatoid Arthritis: A Systematic Review of Cost-Effectiveness Studies
por: Athanasakis, Kostas, et al.
Publicado: (2013) -
Barriers in access to healthcare services for chronic patients in times of austerity: an empirical approach in Greece
por: Kyriopoulos, Ilias-Ioannis, et al.
Publicado: (2014) -
Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting
por: Athanasakis, Kostas, et al.
Publicado: (2013)